[Skip to content]

Print this page
.

NICE Technology Appraisals

This is a list of the published NICE technology appraisals. Technology appraisals are recommendations on the use of new and existing medicines and treatments within the NHS.

NICE TAs: 1-20;  21-40;  41-60;  61-8081-100101-120121-140;  141-160161-180181-200201-220221-240241-260261-280; 281+

NICE TAs 81-100

 

REF

 

TITLE

 

DHFT Formulary link

East Midlands Cancer Network link (cancer drugs only)

TA81

Atopic dermatitis (eczema) - topical steroids (TA81)              

No drug implications           

 

TA82

Atopic dermatitis (eczema) - pimecrolimus and tacrolimus (TA82)

13.5.3 Drugs affecting the immune response

 

TA83

Hernia - laparoscopic surgery (review) (TA83)

No drug implications

 

TA84

Sepsis (severe) - drotrecogin (withdrawn) (TA84) (withdrawn)

Withdrawn

 

TA85 

Renal transplantation - immuno-suppressive regimens (adults) (TA85)

No drug implications

 

TA86

Gastrointestinal stromal tumours - imatinib (TA86)

 

EMCN algorithm

DHFT protocol 

TA87

Osteoporosis - secondary prevention (TA87) (replaced by TA161) (withdrawn)

Withdrawn

 

TA88

Bradycardia - dual chamber pacemakers (TA88)

No drug implications

 

TA89

Cartilage injury - autologous chondrocyte implantation (ACI) (review) (TA89)

No drug implications

 

TA90

Vascular disease - clopidogrel and dipyridamole (TA90) (replaced by TA210)

Withdrawn

 

TA91 

Ovarian cancer (advanced) - paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan (review) (TA91)

 

EMCN algorithm

DHFT protocol

TA92

Tooth decay - HealOzone (TA92)

No drug implications

 

 

TA93

Colorectal cancer (advanced) - irinotecan, oxaliplatin and raltitrexed (TA93) (replaced by CG131)

Withdrawn

 

TA94

Cardiovascular disease - statins (TA94)

2.12 Lipid lowering drugs

 

TA95

Arrhythmia - implantable cardioverter defibrillators (ICDs) (review) (TA95)  

No drug implications

 

TA96

Hepatitis B (chronic) - adefovir dipivoxil and pegylated interferon alfa-2a (TA96)

5.3 Antiviral drugs: 5.3.3 Viral Hepatitis

 

TA97

Depression and anxiety - computerised cognitive behavioural therapy (CCBT) (TA97)

No drug implications

 

TA98

Attention deficit hyperactivity disorder (ADHD) - methylphenidate, atomoxetine and dexamfetamine (review) (TA98)  

4.4 Central nervous stimulants

 

TA99

Renal transplantation - immunosuppressive regimens for children and adolescents (TA99)

No drug implications

 

TA100

Colon cancer (adjuvant) - capecitabine and oxaliplatin (TA100)

 

EMCN algorithm

DHFT protocol 

 

 

 

 

 

 

 

 

: :